Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Cigna Group (CI) Stock Forecast & Price Target

Cigna Group logo
$284.68 +2.66 (+0.94%)
As of 12:53 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Cigna Group - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
5
Buy
16

Based on 21 Wall Street analysts who have issued ratings for Cigna Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 21 analysts, 5 have given a hold rating, 15 have given a buy rating, and 1 has given a strong buy rating for CI.

Consensus Price Target

$339.80
19.36% Upside
According to the 21 analysts' twelve-month price targets for Cigna Group, the average price target is $339.80. The highest price target for CI is $400.00, while the lowest price target for CI is $297.00. The average price target represents a forecasted upside of 19.36% from the current price of $284.68.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for CI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Cigna Group and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CI Analyst Ratings Over Time

TypeCurrent Forecast
5/22/25 to 5/22/26
1 Month Ago
4/22/25 to 4/22/26
3 Months Ago
2/21/25 to 2/21/26
1 Year Ago
5/22/24 to 5/22/25
Strong Buy
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
15 Buy rating(s)
16 Buy rating(s)
16 Buy rating(s)
16 Buy rating(s)
Hold
5 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$339.80$332.47$330.63$379.33
Forecasted Upside19.36% Upside20.92% Upside17.91% Upside21.32% Upside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

CI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Cigna Group Stock vs. The Competition

TypeCigna GroupMedical CompaniesBroader Market
Consensus Rating Score
2.81
2.29
2.52
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside20.12% Upside1,718.28% Upside15.96% Upside
News Sentiment Rating
Positive News

See Recent CI News
Neutral News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/20/2026
Morgan Stanley logo
Morgan Stanley
3 of 5 stars
Erin Wright
Erin Wright
4 of 5 stars
Boost TargetOverweight$355.00 ➝ $361.00+23.90%
5/20/2026
George Hill
George Hill
2 of 5 stars
DowngradeBuyHold$303.00 ➝ $302.00+3.65%
5/5/2026
Lance Wilkes
Not Rated
Boost TargetOutperform$358.00 ➝ $371.00+32.72%
5/4/2026Boost TargetBuy$334.00 ➝ $338.00+19.09%
5/4/2026 Boost TargetBuy$335.00 ➝ $340.00+20.08%
5/1/2026Set Target$340.00+20.01%
5/1/2026Boost TargetOverweight$325.00 ➝ $340.00+19.68%
5/1/2026 Set Target$337.00+18.63%
5/1/2026 Set Target$330.00+16.16%
5/1/2026Boost TargetOverweight$303.00 ➝ $310.00+6.68%
5/1/2026Boost TargetOutperform$333.00 ➝ $337.00+19.19%
5/1/2026Boost TargetEqual Weight$300.00 ➝ $305.00+6.85%
4/20/2026Lower TargetBuy$333.00 ➝ $330.00+18.58%
3/3/2026Lower TargetOverweight$374.00 ➝ $370.00+30.99%
2/17/2026Boost TargetBuy$320.00 ➝ $350.00+20.13%
2/9/2026 Reiterated RatingBuy$375.00+29.04%
2/9/2026Boost TargetBuy$333.00 ➝ $338.00+14.97%
2/6/2026 Boost TargetMarket Perform$270.00 ➝ $297.00+2.82%
1/5/2026 UpgradeStrong SellHold
12/29/2025 Reiterated RatingHold (C-)
11/4/2025Lower TargetOverweight$428.00 ➝ $375.00+42.26%
10/15/2025 Lower TargetOutperform$345.00 ➝ $325.00+10.74%
1/31/2025Lower TargetOutperform$400.00 ➝ $375.00+26.31%
1/31/2025Lower TargetOverweight$410.00 ➝ $380.00+28.89%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 12:53 PM ET.


Should I Buy Cigna Group Stock? CI Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, May 18, 2026. Please send any questions or comments about these Cigna Group pros and cons to contact@marketbeat.com.

Cigna Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in The Cigna Group:

  • The Cigna Group has shown a solid quarterly revenue increase of approximately 4.6% compared to the same quarter last year, indicating strong business performance and growth potential.
  • The current stock price is around $288.91, which reflects a stable valuation in the market, making it an attractive option for investors looking for growth in the health services sector.
  • The company has a favorable dividend yield of 2.1%, providing investors with a steady income stream, which is particularly appealing in a low-interest-rate environment.
  • Analysts have a positive outlook on The Cigna Group, with an average price target of approximately $338.35, suggesting potential for price appreciation in the near future.
  • The Cigna Group's payout ratio is currently at 26.45%, indicating that the company is returning a healthy portion of its earnings to shareholders while still retaining enough capital for growth and investment.

Cigna Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in The Cigna Group for these reasons:

  • Insider selling has been notable, with a total of 205,904 shares sold recently, which may signal a lack of confidence among insiders regarding the company's future performance.
  • Despite the positive revenue growth, the stock has experienced fluctuations, and the recent insider transactions could indicate potential volatility ahead.
  • The company operates in a highly competitive health services market, which could impact its ability to maintain growth and profitability in the long term.
  • With institutional investors holding approximately 86.99% of the stock, any significant changes in their investment strategies could lead to increased volatility in the stock price.
  • Recent analyst ratings show a mix of opinions, with some analysts issuing hold ratings, which may suggest uncertainty about the stock's short-term performance.

CI Forecast - Frequently Asked Questions

According to the research reports of 21 Wall Street equities research analysts, the average twelve-month stock price forecast for Cigna Group is $339.80, with a high forecast of $400.00 and a low forecast of $297.00.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cigna Group in the last twelve months. There are currently 5 hold ratings, 15 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" CI shares.

According to analysts, Cigna Group's stock has a predicted upside of 19.36% based on their 12-month stock forecasts.

Over the previous 90 days, Cigna Group's stock had 1 upgrade and 1 downgrade by analysts.

Analysts like Cigna Group more than other "medical" companies. The consensus rating for Cigna Group is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how CI compares to other companies.


This page (NYSE:CI) was last updated on 5/22/2026 by MarketBeat.com Staff.
From Our Partners